Article

Moderate alcohol consumption may decrease risk of RA

Alcohol consumption is associated with markers of inflammation in patients with rheumatoid arthritis (RA) before symptoms occur. This association suggests that the anti-inflammatory effect of alcohol might be the link between moderate alcohol consumption and a possible decreased risk of RA.

Alcohol consumption is associated with markers of inflammation in patients with rheumatoid arthritis (RA) before symptoms occur. This association suggests that the anti-inflammatory effect of alcohol might be the link between moderate alcohol consumption and a possible decreased risk of RA.

Lu and associates studied 174 participants in the Nurse's Health Study I and II who had blood collected at least 3 months before the onset of RA symptoms. The patients' alcohol consumption was assessed via questionnaire every 4 years. The investigators also gathered information about body mass, cigarette smoking, oral contraceptive use, parity, breast-feeding, age, and menopausal status. Plasma was tested for high-sensitivity C-reactive protein (hsCRP), anti–cyclic citrullinated peptide (anti-CCP) antibody, interleukin (IL)-6, and soluble tumor necrosis factor receptor II (sTNFRII) levels.

There was a U-shaped association between light to moderate alcohol intake and IL-6 levels. Increased daily alcohol consumption reduced the levels of sTNFRII, but alcohol consumption had a questionable effect on hsCRP and anti-CCP levels.

The authors noted that alcohol intake alone may not be powerful enough to influence the risk of RA and that although alcohol consumed in moderation may be protective against inflammatory diseases, alcohol abuse remains a major public health problem.

Related Videos
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
© 2024 MJH Life Sciences

All rights reserved.